Roles of ALL FIT Members
UPDATED on 3/25/2020
OUR Board of Advisors:
TBD from a pool of External Relations
OUR Board Members:
- Prof. Marcus W. Feldman
- Stephen J Williams
OUR Founder:
- Aviva Lev-Ari, PhD, RN
OUR Scientists are:
- Jason Zielonka, MD, AFACC
- Justin D. Pearlman, MD/PhD, FACC
- Stephen J. Williams, PhD
- Irina Robu, PhD
- Sudipta Saha, PhD
- Ofer Markman, PhD
OUR Business Team include:
- Gail – Marketing Communications
- Rick – Business Development & Marketing: Digital Published Products
- Joel Shertok, PhD – Business Development of a Global bot-based Prospecting Cloud-based System
External Affiliations and ex-LPBI
- Medical Doctors: Dr. Larry H. Bernstein (retired), Dr. Pearlman (Central Maine Medical Center), Jason Zielonka, MD, AFACC
- Doctors of Philosophy: Dr. Pearlman, Dr. Williams, Dr. Saha, Dr. Saxena, Dr. Barliya, Dr. Robu, Dr. Nir, Dr. Lev-Ari,, Joel Shertok
- Professors in Academia: Prof. Marcus W. Feldman (Stanford University), Prof. Stephen J. Williams (Temple University), Prof. Sudipta Saha (Amity University Noida, Uttar Pradesh, India), Dr. Irina Robu (Windsor, Ontario, Canada), Adam Sonnenberg, PhD(c), Boston University
- Executives in the biotechnology industry: Gail S. Thornton (Merck USA), Ritu Saxena (Astellas Pharma)
- Executives in high tech industries: Rick Mandahl
FIT members – Who works on WHAT?
UPDATED on 3/25/2020
| Project 1: Coronavirus Portal | Project 2: 2020 BUZ_PLN | Project 3 | Project 4 | Project 5 | |
| OUR Board Members | |||||
| Prof. Marcus W. Feldman, PhD | Content FEEDER | Re-Architect of BUZ_PLN No repetitions | Assist in finding an acquirer among Academic Publishers | Assist in contacting Coursera | Assist in identification of Advisory board members |
| Prof. Stephen J Williams, PhD | see, below | Comments on 4/1/2020 | see, below | see, below | see, below |
| OUR Founder | |||||
| Aviva Lev-Ari, PhD, RN | LAUNCHER AND An Epidemiological Approach AND Diagnosis of Coronavirus Infection by Medical Imaging AND KOLs | Document preparation | Prospecting in person for Acquirers | NLP, ML, AI on Journal Articles e-Book and e-Proceedings | Formalization of Asset Classes Artifacts |
| OUR Science TEAM | |||||
| Jason Zielonka, MD, AFACC | Development of Medical Counter-measures for 2019-nCoV, CoVid19, Coronavirus | Comments on 4/1/2020 | See Roles @LPBI on CV | See Roles @LPBI on CV | See Roles @LPBI on CV |
| Justin D. Pearlman, MD/PhD, FACC | Diagnosis of Coronavirus Infection by Medical Imaging | Comments on 4/1/2020 | WEEKLY One NEW POST | UPDATE own Posts | UPDATE Larry’s Posts |
| Stephen J. Williams, PhD | An Epidemiological Approach AND Community IMPACT | Comments on 4/1/2020 | WEEKLY One NEW POST | UPDATE own Posts | UPDATE Larry’s Posts |
| Irina Robu, PhD | Community IMPACT | Comments on 4/1/2020 | WEEKLY One NEW POST | UPDATE own Posts | UPDATE Larry’s Posts |
| Sudipta Saha, PhD | Voices of Global Citizens | Comments on 4/1/2020 | WEEKLY One NEW POST | UPDATE own Posts | UPDATE Larry’s Posts |
| Ofer Markman, PhD | Key Opinion Leaders Followed by LPBI | Comments on 4/1/2020 | Relationship Development: LPBI and Israel Biotech | Manage relations Noam Ordan and Summer Interns | Relationship Development: Investors in Israel |
| OUR Business Team | |||||
| Gail – Marketing Communications | Voices of Global Citizens | Comments on 4/1/2020 | Newsletter | e-VOICES – Podcast Library Series | Customer Surveys |
| Rick Mandahl – Business Development & Marketing: Digital Published Products | Voices of Global Citizens | Comments on 4/1/2020 and Contact the IB | SelectHealth | Crain Communications | Self Initiated |
| Joel Shertok, PhD – Business Development of a Global bot-based Prospecting Cloud-based System | Economic Impact | Document Preparation | BOT System on Aviva’s LinkedIn connections | BOT systmes on JayZ’s LinkedIn connections | BOT systems on Joel’s LinkedIn connections |
UPDATED on 3/25/2019
| Scientists | Tasks for ALL FIT MEMBERS – UPDATED on 3/24/2019
· UPDATE their CV on the Journal [Completion on 5/15/2019] · New Posts per Commissions to keep Journal ALIVE [Ongoing, EACH SCIENTIST needs to initiate NEW posts and posy per Commissions] · Attend Skypes with FIT members [Sessions are 2 hours long] · Attend Skypes with Investment Banker, as needed · Retweet for · @AVIVA1950 · @pharma_BI · IMPLEMENT GAIL’s Tips for Twitter.com [Ongoing] |
FIT Member’s Progress Report – self documented inside Scientist’s cell | Aviva provides
1. Feedbacks and 2. Defines and Assigns new tasks as needed for Request For Information (RFI) by Investment Banker (IB) |
|
| Dr. Pearlman | IP Valuation Model for Intangibles – work with Aviva
[Concept implementation Will start in May 2019] Please Skype with Aviva ASAP |
|||
| Dr. Williams | 1. Update last 10 articles of SJW & LHB
[Progress report DUE] 2. Reconnect to Social Media [Ongoing] 3. New Posts per Commissions [Ongoing] 4. Review and comments on Section #13 [Progress report DUE] ____________________ |
|||
| Dr. Barliya | 1. Update last 10 articles of TB & LHB’s 10 before last 10
[Progress report DUE] 2. Reconnect to Social Media of own past posts [Progress report DUE] 3. New Posts per Commissions [Ongoing] _________________ |
|||
| Dr. Robu | 1. Weekly Articles Update per list from Aviva
[Progress report DUE] 2. Update last 10 articles of Irina & LHB 20 to 30 lasts [Progress report DUE] 3. New Posts per Commissions [Ongoing] ____________________ |
|||
| Dr. Nir | 1. Update last 10 articles of Dror Nir
[Progress report DUE] 2. New Posts per Commissions [Ongoing] ___________________ |
|||
| Dr. Saxena | 1. SumAll
[Not addressed yet] 2. Collapse Categories [Ongoing] 3. Valuation Model of the Journal, Scoring each Article [Not addressed yet] _______________ |
|||
| Dr. Saha | 1. Update last 10 articles of S. Saha
[Progress report DUE] 2. Reconnect to Social Media [Ongoing] 3. New Posts per Commissions [Ongoing] _________________ |
|||
| Aviva | 1. Forecasting Model per e-Series
2. BioMed eReaders behavior on Amazon – 16 Files 3. Architecture of Positioning Model – to send to IB 4. IP Valuation Model for Intangibles – work with Dr. Pearlman 5. Tweeter Filtering @pharma_Bi for Total Followers’ Followers 6. Identifying Most Honored to be followed by for Tweets by ALL FIT members 7. Sending IB intermediate results 8. Schedule Skype sessions with FIT Members 9. Schedule Skype sessions with IB 10. Schedule Skype sessions with business tycoons in Global markets _______________ |
|||
| Prof. Marc Feldman – Member of the Board | 1. Review Aviva’s Final Reports for editorial and comments [Ongoing]
2. Advice per RFI [Ongoing] 3. Attend Meetings with IB [To be Scheduled] 4. Attend selective meetings with FIT Members per topic [To be Scheduled] _________________ |
|||
| Bus DEV & Marketing Digital Published Products | ||||
| Rick | 1. Competitive Space of LPBI [submitted to Aviva’s satisfaction]
2. Market Plan for +60 Biotech e-Proceedings [PENDING] 3. Journal Subscribers List from WordPress [PENDING] 4. Identify markets for eSeries [PENDING] ________________ |
|||
| AMNON | · Tweeter IMPLEMENT GAIL’s Tips
@pharma_BI @AVIVA1950 [PENDING] Aviva’s 1st level Connections in Biotech/Pharma & Publishing and VC – Global [PENDING] 2. Aviva’s 1st level Connections in Biotech/Pharma and VC – Israel [PENDING] _____________ |
|||
| GAIL
Marketing Communication
|
Gail’s Progress Report on Assigned Tasks, 4/14/2019:
|
|||
Original Created on March 4, 2019
| Scientists | Tasks for ALL FIT MEMBERS
· UPDATE their CV on the Journal · New Posts per Commissions to keep Journal ALIVE · Attend Skypes with FIT members · Attend Skypes with Investment Banker, as needed · Retweet for · @AVIVA1950 · @pharma_BI · IMPLEMENT GAIL’s Tips
|
FIT Member’s Progress Report – self documented inside Scientist’s cell | Aviva provides
1. Feedbacks and 2. Defines and Assigns new tasks as needed for Request For Information (RFI) by Investment Banker (IB) |
|
| Dr. Pearlman | IP Valuation Model for Intangibles – work with Aviva
|
|||
| Dr. Williams | 1. Update last 10 articles of SJW & LHB
2. Reconnect to Social Media 3. New Posts per Commissions |
|||
| Dr. Barliya | 1. Update last 10 articles of TB & LHB’s 10 before last 10
2. Reconnect to Social Media 3. New Posts per Commissions |
|||
| Dr. Robu | 1. Weekly Articles Update per list from Aviva
2. Update last 10 articles of Irina & LHB 20 to 30 lasts 3. New Posts per Commissions |
|||
| Dr. Nir | 1. Update last 10 articles of Dror Nir
2. New Posts per Commissions |
|||
| Dr. Saxena | 1. SumAll
2. Collapse Categories 3. Valuation Model of the Journal, Scoring each Article |
|||
| Dr. Saha | 1. Update last 10 articles of S. Saha
2. Reconnect to Social Media 3. New Posts per Commissions |
|||
| Aviva | 1. Forecasting Model per e-Series
2. BioMed eReaders behavior on Amazon – 16 Files 3. Architecture of Positioning Model – to send to IB 4. IP Valuation Model for Intangibles – work with Dr. Pearlman 5. Tweeter Filtering @pharma_Bi for Total Followers’ Followers 6. Identifying Most Honored to be followed by for Tweets by ALL FIT members 7. Sending IB intermediate results 8. Schedule Skype sessions with FIT Members 9. Schedule Skype sessions with IB 10. Schedule Skype sessions with business tycoons in Global markets |
|||
| Prof. Marc Feldman – Member of the Board | 1. Review Aviva’s Final Reports for editorial and comments
2. Advice per RFI 3. Attend Meetings with IB 4. Attend selective meetings with FIT Members per topic |
|||
| Bus DEV & Marketing Communication | ||||
| Rick | 1. Competitive Space of LPBI
2. Market Plan for +60 Biotech e-Proceedings 3. Journal Subscribers List from WordPress 4. Identify markets for eSeries |
|||
| Amnon | · Tweeter – IMPLEMENT GAIL’s Tips
@pharma_BI @AVIVA1950 1. Aviva’s 1st level Connections in Biotech and VC – Global 2. Aviva’s 1st level Connections in Biotech and VC – Israel |
|||
| GAIL
Marketing Communication
|
|
|||
Roles of ALL FIT Members
OUR Board Members:
- Larry – Medical Leave
- Feldman
OUR Scientists are:
- Justin
- Williams
- Tilda
- Irina
- Dror Nir
- Ritu
- Saha
- Adam [2019 – MD/PhD since LPBI days (2015), Completed format conversion in 2015 for 7 e-Books]
OUR Business Team include:
- Gail – Marketing Communications
- Amnon – Strategy
- Rick – Marketing
2012pharmaceutical
Aashir Awan, Phd
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Daniel Menzin
Dror Nir
dsmolyar
evelinacohn
Gail S Thornton
Irina Robu
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
pkandala
Rosalind Codrington, PhD
ritusaxena
Rick Mandahl
sjwilliamspa
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22